Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Dundee Corp T.DC.A

Alternate Symbol(s):  T.DC.P.B | T.DC.P.D | DNDEF | DNDPF | DDEJF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate Corporation. Corporate and Other Portfolio Holdings segment invests in public and private equity and debt securities in diversified industry segments. Goodman & Company, Investment Counsel Inc. includes the activities of Dundee Global Investment Management Inc. Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. United Hydrocarbon International Corp., an 84%-owned private subsidiary engaged in oil and gas exploration through the holding of a royalty interest in the Republic of Chad.


TSX:DC.A - Post by User

Comment by pierrelebelon Mar 05, 2024 12:17pm
45 Views
Post# 35915974

RE:Taurx article

RE:Taurx article
There is a similar article in Business Today (March 5):

LINK

The same US$15B value is implied "Under a ‘blue sky’ scenario where HMTM is approved and TauRx is valued at USD15b with no discount ascribed to it"

Nothing new as the same US$15B was suggested two years ago.

"Risk-reward profile heavily in favour of reward
TauRx has initiated regulatory engagement in the United Kingdom (Medicines & Healthcare Products Regulatory Agency) and United States (Food & Drug Administration) for product approval."


I think it is a pie in the sky. The way I see it the world's largest drug manufacturers would have spent billions to get a piece of it.  They have not touched TauRx.

<< Previous
Bullboard Posts
Next >>